Literature DB >> 18339811

Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis.

Maud Martin1, Michael Potente, Veerle Janssens, Didier Vertommen, Jean-Claude Twizere, Mark H Rider, Jozef Goris, Stefanie Dimmeler, Richard Kettmann, Franck Dequiedt.   

Abstract

Class IIa histone deacetylases (HDACs) act as key transcriptional regulators in several important developmental programs. Their activities are controlled via phosphorylation-dependent nucleocytoplasmic shuttling. Phosphorylation of conserved serine residues triggers association with 14-3-3 proteins and cytoplasmic relocalization of class IIa HDACs, which leads to the derepression of their target genes. Although a lot of effort has been made toward the identification of the inactivating kinases that phosphorylate class IIa HDAC 14-3-3 motifs, the existence of an antagonistic protein phosphatase remains elusive. Here we identify PP2A as a phosphatase responsible for dephosphorylating the 14-3-3 binding sites in class IIa HDACs. Interestingly, dephosphorylation of class IIa HDACs by PP2A is prevented by competitive association of 14-3-3 proteins. Using both okadaic acid treatment and RNA interference, we demonstrate that PP2A constitutively dephosphorylates the class IIa member HDAC7 to control its biological functions as a regulator of T cell apoptosis and endothelial cell functions. This study unravels a dynamic interplay among 14-3-3s, protein kinases, and PP2A and provides a model for the regulation of class IIa HDACs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339811      PMCID: PMC2290748          DOI: 10.1073/pnas.0708455105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR.

Authors:  Wolfgang Fischle; Franck Dequiedt; Michael J Hendzel; Matthew G Guenther; Mitchell A Lazar; Wolfgang Voelter; Eric Verdin
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

Review 2.  Class IIa histone deacetylases: regulating the regulators.

Authors:  M Martin; R Kettmann; F Dequiedt
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

3.  Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase.

Authors:  B J Michell; T Tiganis; D Stapleton; F Katsis; D A Power; A T Sim; B E Kemp
Journal:  J Biol Chem       Date:  2001-04-05       Impact factor: 5.157

4.  Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.

Authors:  T A McKinsey; C L Zhang; J Lu; E N Olson
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

5.  Mechanism for nucleocytoplasmic shuttling of histone deacetylase 7.

Authors:  H Y Kao; A Verdel; C C Tsai; C Simon; H Juguilon; S Khochbin
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

6.  Sp1 transcriptional activity is up-regulated by phosphatase 2A in dividing T lymphocytes.

Authors:  Isabelle Lacroix; Carol Lipcey; Jean Imbert; Brigitte Kahn-Perlès
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

7.  Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin.

Authors:  Carmen Urbich; Agnes Reissner; Emmanouil Chavakis; Elisabeth Dernbach; Judith Haendeler; Iingrid Fleming; Andreas M Zeiher; Marietta Kaszkin; Stefanie Dimmeler
Journal:  FASEB J       Date:  2002-03-12       Impact factor: 5.191

8.  Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5.

Authors:  Sangeeta Chawla; Peter Vanhoutte; Fiona J L Arnold; Christopher L-H Huang; Hilmar Bading
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

9.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

Review 10.  Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.

Authors:  A B Dounay; C J Forsyth
Journal:  Curr Med Chem       Date:  2002-11       Impact factor: 4.530

View more
  34 in total

1.  A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors.

Authors:  Elisabeth Simboeck; Anna Sawicka; Gordin Zupkovitz; Silvia Senese; Stefan Winter; Franck Dequiedt; Egon Ogris; Luciano Di Croce; Susanna Chiocca; Christian Seiser
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

2.  PP2A regulatory subunit Bα controls endothelial contractility and vessel lumen integrity via regulation of HDAC7.

Authors:  Maud Martin; Ilse Geudens; Jonathan Bruyr; Michael Potente; Anouk Bleuart; Marielle Lebrun; Nicolas Simonis; Christophe Deroanne; Jean-Claude Twizere; Philippe Soubeyran; Paul Peixoto; Denis Mottet; Veerle Janssens; Wolf-Karsten Hofmann; Filip Claes; Peter Carmeliet; Richard Kettmann; Holger Gerhardt; Franck Dequiedt
Journal:  EMBO J       Date:  2013-08-16       Impact factor: 11.598

3.  Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin.

Authors:  David Kaluza; Jens Kroll; Sabine Gesierich; Tso-Pang Yao; Reinier A Boon; Eduard Hergenreider; Marc Tjwa; Lothar Rössig; Edward Seto; Hellmut G Augustin; Andreas M Zeiher; Stefanie Dimmeler; Carmen Urbich
Journal:  EMBO J       Date:  2011-08-16       Impact factor: 11.598

Review 4.  The interface between transcriptional and epigenetic control of effector and memory CD8⁺ T-cell differentiation.

Authors:  Simon M Gray; Susan M Kaech; Matthew M Staron
Journal:  Immunol Rev       Date:  2014-09       Impact factor: 12.988

5.  Protein phosphatases and chromatin modifying complexes in the inflammatory cascade in acute pancreatitis.

Authors:  Javier Escobar; Javier Pereda; Alessandro Arduini; Juan Sandoval; Luis Sabater; Luis Aparisi; Gerardo López-Rodas; Juan Sastre
Journal:  World J Gastrointest Pharmacol Ther       Date:  2010-06-06

6.  C-TAK1 interacts with microphthalmia-associated transcription factor, Mitf, but not the related family member Tfe3.

Authors:  Toni Schwarz; Sharlene Murphy; Chee Sohn; Kim C Mansky
Journal:  Biochem Biophys Res Commun       Date:  2010-03-07       Impact factor: 3.575

Review 7.  Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.

Authors:  Alan J Fowler; Charbel E-H Moussa
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

8.  MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation.

Authors:  Eros Di Giorgio; Andrea Clocchiatti; Sara Piccinin; Andrea Sgorbissa; Giulia Viviani; Paolo Peruzzo; Salvatore Romeo; Sabrina Rossi; Angelo Paolo Dei Tos; Roberta Maestro; Claudio Brancolini
Journal:  Mol Cell Biol       Date:  2013-09-16       Impact factor: 4.272

9.  Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway.

Authors:  Elena Kozhemyakina; Todd Cohen; Tso-Pang Yao; Andrew B Lassar
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

10.  Protein phosphatase 4 regulates apoptosis in leukemic and primary human T-cells.

Authors:  Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Leuk Res       Date:  2009-06-18       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.